Summary & Overview
HCPCS G9083: Prostate Adenocarcinoma Disease Status, Staging In Progress
HCPCS Level II code G9083 captures a specific oncology reporting scenario: documentation of disease status for prostate cancer limited to adenocarcinoma when extent of disease is unknown, staging is in progress, or not listed. The code is designated for use in a Medicare-approved demonstration project and signals cases where staging information is incomplete or pending. Nationally, accurate reporting of such codes matters for clinical tracking, outcomes measurement, and demonstration-project evaluation of cancer staging workflows.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for the code, the typical service settings where it appears (hospital outpatient departments, oncology clinics, and cancer centers), and which payers are relevant for coverage and claims processing. The publication provides benchmarks and coding guidance context where available, summarizes policy considerations tied to demonstration-project use, and outlines common billing themes related to staging documentation and incomplete disease-status reporting.
This summary is intended for national audiences including coding professionals, billing managers, oncology administrators, and policy analysts seeking clarity on the purpose and operational context of HCPCS Level II code G9083. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9083 describes oncology reporting of disease status for prostate cancer, limited to adenocarcinoma, where the extent of disease is unknown, staging is in progress, or not listed. The code is intended for use within a Medicare-approved demonstration project and corresponds to an oncology clinical assessment focused on initial or incomplete staging information for prostate adenocarcinoma.
Service Type: Oncology disease-status reporting and staging assessment
Typical Site of Service: Hospital outpatient departments, oncology clinics, or specialty cancer centers where staging evaluation and documentation occur for prostate cancer patients.
Clinical & Coding Specifications
Clinical Context
A male Medicare beneficiary aged 67 with a recent prostate biopsy showing adenocarcinoma presents to a tertiary oncology clinic for initial disease-status assessment. The patient has an elevated PSA and has undergone pelvic MRI but definitive staging is incomplete pending bone scan and CT abdomen/pelvis. The oncology team documents that extent of disease is currently unknown and staging is in progress for therapy planning and potential enrollment in a Medicare-approved demonstration project.
Workflow: The patient is seen by a medical oncologist or radiation oncologist who performs a focused history and physical, reviews prior pathology and imaging, orders staging studies (bone scan, CT or PET as indicated), records clinical TNM impression as pending, and documents clinical decision-making about next steps. The encounter is billed using G9083 to report disease status for prostate adenocarcinoma when extent of disease is unknown or staging is in progress within the demonstration project context.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no other modifier applies to the service billed with G9083. |